The understanding and management of neuropsychiatric symptoms such as depression and cognitive difficulties in multiple sclerosis (MS) have advanced substantially, but there’s more progress to be made, said Anthony Feinstein, PhD, a neuropsychiatrist and professor of psychiatry at the University of Toronto. Feinstein, who delivered the June Halper Memorial Lecture at the Consortium of Multiple Sclerosis […]

The post CMSC 2026: Neuropsychiatric care in MS has seen major progress appeared first on Multiple Sclerosis News Today.

Source: multiplesclerosisnewstoday.com